Search FTLF
FITLIFE BRANDS, INC.
Nasdaq · CIK 1374328
Last close9.22
Daily change-0.06 (-0.65%)
10 Years gain+3865.59%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
FTLF · STANDARD
SIC 2833 · Medicinal Chemicals & Botanical Products · Fiscal year end 1231
Fundamental
53.6Momentum
n/aAcceleration
n/aConfidence
71.0Annual Revenue11
Quarterly Revenue35
Annual CFO16
Balance SheetMissing
RankingLimited
Score Breakdown
Growth17.6 / 25
Quality18.4 / 25
Capital Efficiency0.0 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 1.1947 percentage points.
Warnings
Inventory anomaly · MEDIUMInventory growth is materially above revenue growth.
Key Metrics
Revenue Growth TTM48.35%OK
Revenue CAGR 3Y6.9%OK
Gross Margin44.56%OK
Operating Marginn/aMISSING
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Yn/aINSUFFICIENT_HISTORY
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | n/a | n/a | n/a | $7.44M | $7.40M | n/a | n/a | n/a | n/a | n/a |
| 2026 FY Dec 31, 2025 | n/a | $6.87M | $2.96M | n/a | n/a | n/a | n/a | n/a | 4.73% | 9.93M |
| 2025 FY Dec 31, 2024 | n/a | $28.08M | $13.12M | $9.61M | $9.60M | n/a | n/a | n/a | 20.6% | 9.9M |
| 2024 FY Dec 31, 2023 | n/a | $21.43M | $7.55M | $4.22M | $4.11M | n/a | n/a | n/a | 16.66% | 9.81M |
| 2023 FY Dec 31, 2022 | n/a | $12.03M | $5.70M | $4.13M | $4.13M | n/a | n/a | n/a | 22.39% | 4,975 |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $27.93M | sum latest 4 fiscal quarters Revenue | OK | 0001851734-21-000065, 0001654954-21-005641 |
| Revenue Growth TTM | 48.35% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001851734-21-000065, 0001654954-21-005641 |
| Revenue CAGR 3Y | 6.9% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001654954-21-003364 |
| Revenue CAGR 5Y | 3.93% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001654954-21-003364 |
| Gross Profit CAGR 3Y | 22.65% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001654954-21-003364 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 44.56% | Gross Profit / Revenue | OK | 0001851734-21-000065, 0001654954-21-005641 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | derived |
| Current Ratio | 3.75x | Current Assets / Current Liabilities | OK | derived |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | 0001851734-22-000611 |
| Diluted EPS TTM | n/a | Net income TTM / Diluted shares | NOT_MEANINGFUL | derived |
| Gross Margin Delta 1Y | +1.19 pp | GrossMargin_current - GrossMargin_prior_year | OK | 0001851734-21-000065, 0001654954-21-005641 |